Opaleye Management »

Q32 Bio shares owned by Opaleye Management

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by Opaleye Management from 13F filings

Historical chart of Opaleye Management investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by Opaleye Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by Opaleye Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $708k 213k 3.32

More positions owned by Opaleye Management

Harrow Health (HROW)
Liquidia Corporation Com New (LQDA)
Eton Pharmaceuticals (ETON)
Rhythm Pharmaceuticals (RYTM)
Apogee Therapeutics (APGE)
Sanuwave Health (SNWV)
Stoke Therapeutics (STOK)
Ocular Therapeutix (OCUL)
Sol Gel Technologies Shs New (SLGL)
Cg Oncology (CGON)
Tg Therapeutics (TGTX)
Disc Medicine (IRON)
Rezolute Com New (RZLT)
Crescent Biopharma (CBIO)
Alkermes SHS (ALKS)

View all positions for Opaleye Management

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
Carlyle
Acorn Capital Advisors
Vanguard Group
Arch Venture Corp
Pfizer
Sanofi
Opaleye Management
Trustees of Columbia University in the City of New York
Geode Capital Management
Millennium Management
Renaissance Technologies
BlackRock
Monaco Asset Management SAM

View all funds holding Q32 Bio